Hope Tribune

UK Healthcare Outlook Report, 2021 by DelveInsight

 Breaking News
  • No posts were found

UK Healthcare Outlook Report, 2021 by DelveInsight

November 30
12:16 2021
UK Healthcare Outlook Report, 2021 by DelveInsight
DelveInsight Business Research LLP
DelveInsight’s,“UK Healthcare Outlook Report, 2020,” provides comprehensive insights about healthcare scenario, regulatory policies and reimbursement landscape in UK.

UK Healthcare Outlook Report

DelveInsight’s,“UK Healthcare Outlook Report, 2020,” provides comprehensive insights about healthcare scenario, regulatory policies and reimbursement landscape in UK. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market of UK.

 

As per DelveInsight’s analysis, UK has a globally unique health and life sciences ecosystem. NHS offers a national research and evidence gathering platform with unique data and clinical insights. Track record of scientific breakthroughs is driving the next generation of life-changing treatments, technologies and services. There are a number of regulatory bodies in place which monitor and assess the quality of health services provided by public and private providers. Quality issues are addressed in a variety of methods. There as certain disadvantageous side effects to the government’s participation in the healthcare system. Their active role in healthcare weakens the functionality of market mechanisms. In addition, the tight control undertaken in regards to medical expenses has resulted in a lack of medical resources, such as equipment, doctors and nurses in public hospitals.

 

Medical Device

An important development for life science businesses is the publication of the Medicines and Medical Devices Bill. As expected, this draft legislation will provide for the UK Government to take over the rulebook for human and veterinary medicines, clinical trials and medical devices after the end of the transition period on 31st December 2020. Currently very closely harmonized at EU level, the legislation is not expected to diverge rapidly from EU law.

 

However, there are clear signals in the Bill and Explanatory Notes that a separate approach is likely to evolve.

 

Legislation in this area has previously been updated at EU level, with the changes flowing through into UK law. The Medicines and Medical Devices Bill will allow the Health Secretary to take over that task. The Bill proposes similar powers to amend or supplement the medical devices legislation. Of course, the existing EU directives in this area are due to be replaced by two new Regulations:

  • Regulation 2017/745 on medical devices (applicable from 26 May 2020)
  • Regulation 2017/746 on in vitro diagnostic medical devices (applicable from 26 May 2022).

 

Key Players

  • The Harley Street Clinic
  • Portland Hospital
  • Ramsay Health Care UK
  • Synergy Health
  • Nuffield Health
  • GlaxoSmithKline
  • Oxford BioLabs
  • Spire Healthcare
  • Allied Healthcare
  • Circle Health Ltd

 

Request for sample pages @ Uk Healthcare Outlook Report 

Table of contents

1. Key Insights

2. UK at a Glance

3. Executive Summary

3.1. Overview

3.2. Key Reforms in UK Healthcare Market

3.3. Healthcare Facility Administrative Structure

3.4. Governmental Healthcare Policy

3.5. Industry Overview

3.5.1. Pharmaceutical

3.5.1.1. Supply Channels

3.5.1.2. Major Players

3.5.1.3. Prescription VS OTC Drugs

3.5.2. Medical Device

3.5.2.1. Supply Chain

3.5.2.2. Major Distributors

3.6. Strategic Location

3.7. COVID-19 Update

3.8. Healthcare Technology Update

4. Assessment

4.1. Healthcare

4.1.1. Healthcare Facilities (Beds, Hospitals and Pharmacy)

4.1.2. Life Expectancy and Immunization Rate

4.1.3. Environmental Health (PM2.5 and CO2)

4.1.4. Healthcare Workforce (Physicians, Dentists and Nurses)

4.1.5. Healthcare Expenditure as share of GDP

4.1.6. Healthcare Expenditure

4.1.7. Out of Pocket Expenditure as share of current health expenditure

4.1.8. Pharmaceutical Imports and Exports

4.2. Economic

4.2.1. Gross Domestic Product

4.2.2. Inflation

4.2.3. Unemployment

4.2.4. Trade Association, UK

4.2.5. Trade Fairs, UK

5. Market Access

5.1. Overview of Healthcare System Regulatory Bodies, UK

5.2. Reimbursement Process, UK

5.3. Health Insurance, UK

5.4. Pricing Policies, UK

5.5. Regulatory Landscape, UK

5.5.1. Market Authorization for Pharmaceutical Products, UK

5.5.2. Market Authorization for Medical Devices, UK

5.5.3. Licensing Process for Pharmaceutical and Medical Device Manufacturing, UK

5.5.4. Licensing Process for Pharmaceutical Exports and Imports, UK

5.5.5. Intellectual Property Rights, UK

5.5.5.1. Patent

5.5.5.2. Trademark

5.5.6. Clinical Trial Regulations, UK

5.5.6.1. Pharmaceutical Clinical Trials Landscape, UK

5.5.6.2. Medical Device Clinical Trials Landscape, UK

5.5.7. Pharmaceutical Advertising Regulations, UK

5.5.8. Medical Device Advertising Regulations, UK

5.5.9. Pharmacy Regulations, UK

5.5.10. Labeling and Packaging Regulations, UK

6. UK PESTLE Analysis

7. Driver and Barriers

8. Appendix 

8.1. Research Methodology

8.1.1. Coverage

8.1.2. Secondary Research

9. References

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/